Deutsche Bank downgrades MedCath Corporation (Nasdaq: MDTH) from Buy to Hold. Price target lowered from $14 to $12.50.

This article: 137 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE